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Aspergillus march: from ABPA 
to aspergilloma to subacute invasive 
aspergillosis
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Abstract 
Background: Aspergillus is a ubiquitous fungus responsible for allergic as well as saprophytic and invasive manifesta-
tions depending on host’s immune status. The following case report demonstrates progression of allergic manifesta-
tions of Aspergillus to its invasive form in an individual with decreasing immunity. This can lead to uncertainties in 
diagnosis and management.
Case presentation: A 28-year-old male, non smoker, known case of ABPA (allergic bronchopulmonary aspergillosis) 
was admitted with complaints of cough for 1 month, associated with recurrent episodes of hemoptysis for last 5 days. 
CT Thorax revealed homogenous dense round opacity in right upper lobe which replaced previous fibrocalcific 
bronchiectatic lesion with cavity and aspergilloma, bulging across the major fissure with fibrotic strands extending 
to periphery in all directions. Post-pneumonectomy microscopic examination revealed Aspergillus hyphae invading 
blood vessels.
Conclusion: There is a need for close clinical and radiologic follow up of patients with Aspergillus and our patient 
demonstrated overlap of complete spectrum of Aspergillus disease with march from one end to the other end.
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Background
Aspergillus is a fungus with ubiquitous presence. It is 
responsible for spectrum of diseases depending upon the 
host immune status varying from allergic bronchopul-
monary aspergillosis (ABPA) in atopics, aspergilloma 
in chronic lung cavity, and chronic pulmonary aspergil-
losis (CPA) or invasive pulmonary aspergillosis (IPA) in 
immunocompromized. However, overlap among them 
has been observed as immune status changes because of 
treatment with steroids for ABPA or development of dia-
betes which itself leads to immunosuppression. We pre-
sent a rare case with ABPA which progressed to develop 
aspergilloma and finally to subacute invasive aspergillosis 
over a period of 10 years.
Case presentation
A 28-year-old male, non smoker, known case of ABPA 
was admitted with complaints of cough with scant expec-
toration for 1 month, associated with recurrent episodes 
of hemoptysis for last 5 days. He had been diagnosed as 
ABPA 10 years back with Skin Prick Test (SPT) strongly 
positive for Aspergillus fumigatus, flavus and niger. Total 
Serum IgE was 1200  KU/L with specific IgE and IgG 
positive against A. fumigatus. He was on treatment with 
steroids for the same. 5 years ago he was admitted with 
mild hemoptysis, fever and breathlessness for 2  weeks. 
Contrast enhanced CT chest showed mucoid impaction 
(HAM—High attenuation mucus) and central bronchiec-
tasis in right upper lobe (Fig. 1). He received Itraconazole 
for 4  months. Subsequently, he had repeated admis-
sions for 3 consecutive years with similar complaints and 
repeat CT done revealed fibrocalcific lesion in apical and 
posterior segments of right lung upper lobe with a cav-
ity showing soft tissue attenuation and air crescent sign 
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suggestive of mycetoma (Fig. 2). He was advised surgery, 
which was deferred by patient and he took Voriconazole 
for 6  weeks and later itraconazole for 6  months from 
elsewhere and was lost to follow up. He had been on oral 
steroids for 10 years receiving on an average 6 months of 
steroids (Prednisolone starting from 60 mg then tapered). 
For last 2  years he was on oral Deflazacort 12  mg with 
doses increased during exacerbations.
At present admission his resting peripheral capillary 
oxygen saturation was 89% on room air. Chest X ray 
revealed hyperinflated lung fields with focal homoge-
nous opacity with infiltrates in right upper zone (Fig. 3). 
CT Thorax revealed homogenous dense round opacity 
in right upper lobe which replaced previous fibrocalcific 
bronchiectatic lesion with cavity and aspergilloma, bulg-
ing across the major fissure with fibrotic strands extend-
ing to periphery in all directions. Sputum smears and 
culture examinations for mycobacteria, and fungi were 
negative.
In view of recurrent hemoptysis, unilateral disease and 
worsening radiological disease with acceptable lung func-
tions, patient underwent thoracotomy. The lesion was 
found to be extending across major fissure with involve-
ment of right lower lobe apical segment and decision 
for pneumonectomy was taken. Gross examination of 
resected lung showed cavity in the upper lobe filled with 
solid debris (Fig.  4A) which on microscopic examina-
tion shows fungal colonies comprising of acutely branch-
ing septate fungal hyphae with invasion of surrounding 
bronchi, alveolar tissues and blood vessels. Surrounding 
parenchyma showed emphysematous changes with sep-
tate branching fungal hyphae and minimal fibrosis of 
the cavity wall and surrounding pleural consistent with 
the diagnosis of complex mycetoma with locally invasive 
aspergillosis (Fig. 4B–D). Few central bronchiectatic seg-
ments were seen in the upper lobe.
Patient had uneventful recovery and is doing well. His 
serum galactomannan was 2.5 and given oral voricona-
zole for 6  weeks and repeat serum galactomannan was 
negative and now patient is being regularly followed in 
OPD.
Discussion
Aspergillus causes a spectrum of diseases depending 
upon the immune status of the host (Table 1) [1].
Both ABPA and aspergilloma are its noninvasive forms. 
Aspergilloma is a fungus ball that develops in a pre-exist-
ing cavity within the lung parenchyma, while ABPA is a 
hypersensitivity manifestation in the lungs that almost 
always affects patients with asthma or cystic fibrosis. Tis-
sue necrosis and invasion of blood vessels does not occur. 
Aspergillomas presenting with recurrent hemoptysis are 
treated by surgery. Our case also highlights failure of 
antifungals in management of aspergillomas as patient 
tried though for limited period to avoid surgery.
Subacute invasive pulmonary aspergillosis (SAIA) or 
Chronic Necrotizing Aspergillosis is a locally invasive 
disease manifesting as a syndrome of slowly progressive 
Fig. 1 CXR showing right upper lobe opacity which on HRCT showed central bronchiectasis in right upper lobe anterior segment
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cavitary lung disease, chronic respiratory symptoms, and 
the presence of precipitating antibodies to Aspergillus [2]. 
It typically occurs in patients with a depressed immune 
system, but not as profoundly immunocompromised [2]. 
It is commonly observed in diabetics, patients on corti-
costeroids or with underlying lung disease like COPD. 
SAIA usually runs a slowly progressive course over weeks 
to months. It is the finding of tissue invasion that allows 
Fig. 2 HRCT cuts from 2009 to 2014 showing development of aspergilloma in right upper lobe which grew over 5 years
Fig. 3 A Chest Xray showing opacity right upper lobe B HRCT sagittal cut showing expanded aspergilloma pushing across oblique fissure with 
peripheral infiltrates
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this entity to be distinguished from the more common 
aspergilloma.
Invasive pulmonary aspergillosis (IPA) is a severe dis-
ease, found in immunocompromised patients. Certain 
factors have been documented to predispose an individ-
ual to IPA (Table 2) [3.
There are reports documenting IPA in immunocom-
petent patients who do not have the clearly known risk 
factors especially severe COPD and critically ill patients 
[4].
Aspergilloma is an unusual complication of ABPA. 
Cavitation is known to occur in ABPA but still asper-
gilloma formation is not common. There have been 
case reports documenting aspergilloma and ABPA in 
patients with difficult to control asthma [5]. A case 
series of 179 patients of ABPA out of which eight also 
had aspergilloma concluded that concurrent presenta-
tion of ABPA and aspergilloma was associated with an 
immunologically severe disease with higher IgE levels 
Fig. 4 A Gross right pneumonectomy specimen with large fungus ball in cavity with fibrosis. B Lung parenchyma blood vessel showing infiltration 
with fungal hyphae). C Intra bronchial fungal elements. D fungal ball showing acutely branching septate hyphae of Aspergillus
Table 1 Manifestations of pulmonary aspergillosis
Simple colonization
Allergic bronchopulmonary aspergillosis (ABPA)
Chronic pulmonary aspergillosis
Simple aspergilloma
Chronic cavitary pulmonary aspergillosis (CCPA)
Chronic fibrosing pulmonary aspergillosis
Aspergillus nodule
Subacute invasive aspergillosis (SAIA)
Angioinvasive aspergillosis
Airway invasive aspergillosis
Table 2 Classical risk factors for  invasive pulmonary 
aspergillosis
Prolonged neutropenia (<500 cells/mm3 for >10 days)
Transplantation (highest risk is with lung transplantation and HSCT)
Prolonged (>3 weeks) and high-dose corticosteroid therapy
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and more extensive bronchiectasis and risk of recurrent 
relapses [6]. Spontaneous disappearance of aspergilloma 
has been reported in 5% of cases while they rarely have 
been reported to increase in size [7]. Thickening of cav-
ity wall and adjacent pleura has been demonstrated to be 
due to hypersensitivity reaction secondary to fungus as 
its reversible with resolution of aspergilloma. A chronic 
mycetoma may suddenly breakdown and become a rap-
idly invasive pulmonary infection.
A case report by Shah et al. found ABPA, AAS (allergic 
Aspergillus sinusitis), and aspergilloma occurring simul-
taneously in the same patient [8].
In present case development of ‘Simple Aspergil-
loma’ in ABPA was observed at follow up, which kept on 
increasing in size with destruction of surrounding lung 
parenchyma and pleural thickening converting it into a 
‘Complex Aspergilloma’. It eventually became invasive in 
the same patient. Possible reason might have been immu-
nocompromized due to corticosteroid therapy, which 
he received for management of ABPA. This presents a 
unique therapeutic challenge, as corticosteroids are the 
mainstay for management of ABPA.
Subacute invasive aspergillosis presents clinically with 
non specific symptoms with mild to moderate hemop-
tysis. Radiologically dense circumscribed lesion with or 
without halo sign is seen. Positive Aspergillus on micros-
copy from biopsy specimen and positive serum antigen 
test for Aspergillus are also observed. All these features 
have been demonstrated in our case. In such cases surgi-
cal resection is indicated if significant hemoptysis occurs. 
In addition to serving as a diagnostic tool, serial galacto-
mannan determinations have been suggested to be useful 
for monitoring the treatment response or as a surrogate 
endpoint for outcomes of invasive aspergillosis.
Conclusion
Our patient demonstrated overlap of complete spectrum 
of Aspergillus disease with march from one end to the 
other end. This case emphasizes importance of regular 
clinical and radiologic follow up of patients with ABPA.
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